Accubiotech Co.,Ltd

Call Directions Website Contact the business

Accubiotech Co.,Ltd AccuBioTech Co., Ltd. is a biotech company specializing in developing, manufacturing and distribution of in vitro rapid diagnostic tests and Lab Equipment.

AccuBioTech has established and applied a quality management system for medical devices according to the requirements specified in EN ISO 13485:2016. Over 50 of our products are CE marked.

Simplify Saliva Drug Screening with Accu-Tell®Looking for a flexible saliva drug testing solution for your market?The Ac...
21/10/2026

Simplify Saliva Drug Screening with Accu-Tell®
Looking for a flexible saliva drug testing solution for your market?
The Accu-Tell® Multi-Drug Midstream Pro (Saliva) offers:
✔ Convenient, integrated saliva collection
✔ Detection options for key drug targets, including THC and COC
✔ Multiple configurations covering 2–14 drug classes
✔ Results in 10 minutes
✔ Compatibility across all models with our Accu-Tell® Lateral Flow Reader (RDP-700)
Explore our saliva drug testing portfolio and find options that fit your market needs.
📩 Contact AccuBioTech to learn more.
🌐 https://www.accubiotech.com/

Early Answers Matter.When it comes to pregnancy testing, choosing the right test format matters.Accu-Tell® HCG Pregnancy...
16/10/2026

Early Answers Matter.
When it comes to pregnancy testing, choosing the right test format matters.
Accu-Tell® HCG Pregnancy Rapid Tests are designed for the qualitative detection of human chorionic gonadotropin (hCG) in urine, helping support early pregnancy detection.
Our urine-based portfolio offers three formats:
HCG Cassette
HCG Strip
HCG Midstream
With a sensitivity of 25 mIU/mL and a 5-minute reading time listed for the urine product range, the portfolio offers practical options for different market needs.
For distributors, healthcare brands and OEM/ODM partners, AccuBioTech provides a range of rapid diagnostic solutions to support your product portfolio.
Explore our HCG products:
https://www.accubiotech.com/product-hcg-pregnancy-rapid-test-cassette-midstream-strip-urine.html

Timing Matters. ⏱️Understanding ovulation timing is an important part of fertility monitoring.The luteinizing hormone (L...
10/10/2026

Timing Matters. ⏱️
Understanding ovulation timing is an important part of fertility monitoring.
The luteinizing hormone (LH) surge typically occurs before ovulation. Detecting this rise in urine can help identify the approaching fertile window and support informed family planning.
At AccuBioTech, our Accu-Tell® LH rapid test portfolio offers three formats:
🔹 LH Cassette
🔹 LH Strip
🔹 LH Midstream
Different formats. One focus: supporting ovulation monitoring.
For diagnostic distributors, women's health brands, and healthcare partners, a versatile product portfolio can help address different market needs.
📩 Contact us to learn more about our LH rapid test solutions.
🌐 https://www.accubiotech.com/product-list-accu-tell-fertility-rapid-tests.html

Why does ToRCH screening matter?Some maternal infections may present with few or no symptoms, yet they can have importan...
03/10/2026

Why does ToRCH screening matter?
Some maternal infections may present with few or no symptoms, yet they can have important implications for fetal and newborn health.
In this educational carousel, we break down the four key components of ToRCH screening and explain why awareness remains an important part of maternal healthcare.
✔ Toxoplasmosis
✔ Rubella
✔ Cytomegalovirus (CMV)
✔ Herpes Simplex Virus (HSV)
Understanding risks is the first step toward better maternal and neonatal health.
'sHealth

One Panel. Multiple Insights.Maternal infection screening often involves evaluating multiple pathogens, which can increa...
30/09/2026

One Panel. Multiple Insights.
Maternal infection screening often involves evaluating multiple pathogens, which can increase workflow complexity and resource requirements.
The Accu-Tell® ToRCH IgG/IgM Combo is designed to simplify screening by supporting the detection of key ToRCH markers within a single testing workflow.
In this carousel, we explore:
✔ Why maternal screening matters
✔ The four key infection categories included in ToRCH screening
✔ The value of comprehensive screening approaches
✔ How streamlined workflows can support healthcare providers
Learn more about our maternal screening solutions:
🌐 www.accubiotech.com
'sHealth

One Test. Four Critical Infections.Screening for multiple infectious diseases often requires multiple tests, additional ...
29/09/2026

One Test. Four Critical Infections.
Screening for multiple infectious diseases often requires multiple tests, additional procedures, and more resources.
The Accu-Tell® HBsAg/HCV/HIV/Syphilis Combo Cassette is designed to simplify the screening workflow by enabling rapid detection of four important infectious disease markers in a single test device.
✔ HBsAg
✔ HCV Antibody
✔ HIV 1/2 Antibody
✔ Syphilis Antibody
Designed for professional use and suitable for a variety of healthcare screening settings.

Ebola Outbreak 2026: Why Early Detection MattersThe 2026 Bundibugyo virus disease outbreak in the Democratic Republic of...
22/09/2026

Ebola Outbreak 2026: Why Early Detection Matters
The 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo continues to highlight the importance of timely case detection and diagnostic capacity.
According to the latest WHO update, as of 7 September 2026, the outbreak had resulted in 6,757 confirmed cases and 3,267 deaths across 61 health zones in the DRC.
In rapidly evolving outbreaks, diagnostic tools need to support healthcare teams where testing is needed — including primary healthcare facilities, community settings, and field laboratories.
The Accu-Tell® Ebola Virus Antigen Cassette (Whole Blood/Serum/Plasma) is a rapid lateral flow immunoassay for the qualitative detection of Ebola virus antigens.
Key features include:
• Whole blood, serum and plasma specimens
• Fingerstick whole blood option for point-of-care use
• Results available within 15–20 minutes
• Lateral flow immunoassay format
• Designed for professional IVD use
• Suitable for community settings, primary healthcare facilities and field laboratories
Rapid testing is not a replacement for confirmatory molecular testing.
Instead, it can be part of a broader diagnostic workflow that supports timely identification and further evaluation of suspected cases.
Rapid Screening. Practical Testing. Supporting Timely Response.
AccuBioTech — Reliable Solutions for Rapid Diagnostics.

How can healthcare systems improve preparedness during infectious disease outbreaks?Rapid and accessible diagnostic tech...
17/09/2026

How can healthcare systems improve preparedness during infectious disease outbreaks?
Rapid and accessible diagnostic technologies are becoming increasingly important in supporting outbreak response, especially where laboratory resources may be limited.
From early identification to expanded testing access, diagnostics play a critical role in strengthening public health readiness.
In this first installment of our Ebola Preparedness Series, we explore:
✔ Why early detection matters
✔ Challenges in outbreak diagnostics
✔ The role of rapid testing technologies
✔ Building stronger diagnostic readiness
Swipe through to discover more.

Fast screening plays a critical role in modern drug monitoring.When organizations need to process large numbers of sampl...
09/09/2026

Fast screening plays a critical role in modern drug monitoring.
When organizations need to process large numbers of samples, rapid testing provides an efficient first-line screening solution before laboratory confirmation.
Powered by immunochromatographic technology, rapid drug tests offer:
✅ Results within minutes
✅ Simple operation
✅ Flexible application scenarios
✅ Cost-effective screening solutions
From workplace safety to clinical monitoring and public safety programs, AccuBioTech® supports partners with reliable Accu-Tell® Drug Rapid Test Solutions designed for efficient preliminary screening.
Discover how rapid diagnostics can improve drug monitoring workflows.

🔬 Advancing Cannabinoid Testing with Smarter Screening SolutionsAs testing needs continue to evolve, the future of canna...
04/09/2026

🔬 Advancing Cannabinoid Testing with Smarter Screening Solutions
As testing needs continue to evolve, the future of cannabinoid screening is not only about what we detect—but also how efficiently, reliably, and practically we can deliver results.
Different specimens, detection windows and analytical approaches create different testing needs. For laboratories, healthcare providers, workplaces and public safety programs, the challenge is to build workflows that balance reliability with efficiency.
At AccuBioTech, we believe rapid screening can play an important role in this evolving testing landscape.
Our focus is to develop practical, reliable and accessible rapid diagnostic solutions that support efficient first-line screening and complement laboratory confirmation when needed.
Accurate. Simple. Practical.
This is more than a product philosophy.
It is our approach to helping laboratories and testing programs build better testing workflows.
As cannabinoid testing continues to advance, AccuBioTech remains committed to bringing diagnostic technology closer to real-world testing needs.
📖 Explore our latest industry insight:
Scientific Basis and Development of Cannabinoid Detection: From Metabolism to Testing Challenges

Address

Beijing
101300

Alerts

Be the first to know and let us send you an email when Accubiotech Co.,Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Accubiotech Co.,Ltd:

Shortcuts

Share